Skip to content

Music Therapy for Oral Mucositis Pain in Pediatric Patients

Effect of Music Therapy on Oral Mucositis Pain in Pediatric Patients

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07653360
Enrollment
50
Registered
2026-06-17
Start date
2026-09-01
Completion date
2027-07-31
Last updated
2026-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mucositis Oral, Oral Mucosa Discomfort, Pediatric Cancer

Keywords

Music Therapy

Brief summary

This mixed-methods pilot study will examine the effect of music therapy on oral mucositis pain in pediatric oncology patients. Oral mucositis, characterized by painful ulcerative lesions in the mouth, is a common side effect of high-dose chemotherapy and hematopoietic stem cell or bone marrow transplantation. Despite its high prevalence and impact on quality of life, effective pain management strategies for pediatric oral mucositis remain limited and often rely heavily on medications that may cause significant side effects or provide insufficient relief. Music therapy may offer a promising non-pharmacologic adjunct for reducing pain, yet no studies to date have specifically evaluated its use for oral mucositis pain in pediatric patients.

Detailed description

Phase 1: Aim 1a: Explore the experiences of oral mucositis pain in pediatric patients. Aim 1b: Explore how pediatric patients perceive the involvement of music therapy during oral mucositis pain. Phase 1 of the study involves semi-structured interviews with parent-child dyads about the child's experiences with oral mucositis and their perceptions of music therapy while experiencing oral mucositis pain. Information obtained in Phase 1 will direct the development and design of the Interventional Phase (Phase 2) not yet enrolling.

Interventions

OTHERSemi-Structured Interviews

Participants will be interviewed online via Zoom

Sponsors

University of California, San Francisco
Lead SponsorOTHER
Perloff Family Foundation
CollaboratorUNKNOWN

Study design

Allocation
NA
Intervention model
SEQUENTIAL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Intervention model description

Phase 2 of the study will open for enrollment after Phase 1 has been completed.

Eligibility

Sex/Gender
ALL
Age
6 Years to 64 Years
Healthy volunteers
Yes

Inclusion criteria

Phase 1 * Child ages 6-18 years old * Child has received music therapy and experienced oral mucositis * Parent/guardian 18 years and older * Able to communicate in English

Exclusion criteria

Phase 1 * Diagnosis of a developmental disorder that would prevent engagement in the active music-making or passive music-listening intervention or completion of study measures. * Significant pre-existing hearing loss or impairment that would interfere with participation in the interventions.

Design outcomes

Primary

MeasureTime frameDescription
Identify patterns in previous experience with music therapy1 daySemi-structured interviews will be audio/video-recorded and transcribed using Zoom's built-in transcription function. Finalized transcripts will be analyzed using reflexive thematic analysis, a qualitative method for identifying and interpreting patterns within the data.

Countries

United States

Contacts

CONTACTJonathan Tang, MT-BC, PhD
Jonathan.Tang2@ucsf.edu(415) 353-3327
PRINCIPAL_INVESTIGATORWei Li Jonathan Tang, MT-BC, PhD

University of California, San Francisco

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 19, 2026